IRCT20180819040830N4RecruitingPhase 3
Evaluation of Efficacy and Safety of Enoxaparin in Treatment of Vascular Intra-Uterine Growth Retardation: A Randomized Clinical Trial
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Recruiting
- Enrollment
- 126
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to no limit (—)
- Sex
- Female
Inclusion Criteria
- •>18 years old women with singleton pregnant women
- •Diagnosis of intra-uterine growth retardation for their fetus
Exclusion Criteria
- •Maternal age <18 years old
- •Multiple pregnanvy
Investigators
Similar Trials
Recruiting
Phase 3
The effectiveness of enoxaparin in preventing deep vein thrombosisDeep vein thrombosis.Phlebitis and thrombophlebitis of other deep vessels of lower extremitiesI80.2IRCT20210602051484N1Zanjan University of Medical Sciences200
Not yet recruiting
Not Applicable
Assessment of validity and safety in Enoxaparin administration soon after cesarean section.venous thromboembolism (VTE)JPRN-UMIN000009068Obstetrics and Gynecology, Hamamatsu University School of Medicine160
Completed
Phase 3
Safety and usefulness of Enoxaparin versus unfractionated heparin in patients with ST elevation myocardial infarctioIschaemic heart diseases.Acute myocardial infarctionIRCT138711271695N1Tehran University of Medical Sciences and Health Services150
Recruiting
Not Applicable
The study of he efficacy of combination enoxaparin and physical therapy for perioperative venous thrombosis (VTE) prevention after laparoscopic colon cancer surgeryvenous thromboembolism (VTE)JPRN-UMIN000033749Hyogo college of Medicine302
Completed
Phase 2
Safety and efficacy of Enoxaparine sodium after oncogynecological surgical patients:phase 2 studygynecological cancerJPRN-UMIN000003246Kansai clinical oncology group100